New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.
New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.
复制标题
DOI:
10.1007/s12265-013-9462-3
复制
发表时间:
2013-08
影响因子:
3.4
通讯作者:
Sam, Flora
中科院分区:
文献类型:
--
作者:
Gopal, Deepa M.;Sam, Flora
Dilated cardiomyopathy (DCM) is characterized by deteriorating cardiac performance and impaired contraction and dilation of the left (or both) ventricles. Blood markers – known as “biomarkers” allow insight into underlying pathophysiologic mechanisms and biologic pathways, while predicting outcomes and guiding heart failure management and/or therapies. In this review, we provide an alternative approach to conceptualize heart failure biomarkers: the cardiomyocyte, its surrounding microenvironment, and the macroenvironment with clear interaction between these entities which may impact cellular processes involved in the pathogenesis and/or propagation of DCM. Newer biomarkers of left ventricular systolic dysfunction can be categorized under: (a) myocyte stress and stretch, (b) myocyte apoptosis, (c) cardiac interstitium, (d) inflammation, (e) oxidative stress, (f) cardiac energetics, (g) neurohormones and (h) renal biomarkers. Biomarkers provide insight into the pathogenesis of DCM while predicting and potentially providing prognostic information in these patients with heart failure.
登录
查看更多内容
DOI:
10.1136/hrt.2010.194878
发表时间:
2010-08
期刊:
Heart (British Cardiac Society)
影响因子:
--
作者:
Damman K;Van Veldhuisen DJ;Navis G;Vaidya VS;Smilde TD;Westenbrink BD;Bonventre JV;Voors AA;Hillege HL
通讯作者:
Hillege HL
影响因子:
4.6
作者:
Carubelli, Valentina;Metra, Marco;Dei Cas, Livio
通讯作者:
Dei Cas, Livio
影响因子:
3.5
作者:
Chu, John W.;Jones, Gregory T.;Williams, Michael J. A.
通讯作者:
Williams, Michael J. A.
影响因子:
2.8
作者:
Cicoira, M;Zanolla, L;Zardini, P
通讯作者:
Zardini, P
影响因子:
5.7
作者:
George, J.;Patal, S.;Roth, A.
通讯作者:
Roth, A.